Clinical Trials provide access to emerging therapies. Trial eligibility can depend on your diagnosis, prior treatment history, and sometimes tissue availability/requirements.
Clinical trials can offer access to new approaches earlier than standard availability. For many patients, a trial isn’t a last resort—it’s a strategic option.
Patients often feel buried by:
Trial matching support helps narrow the field to options that are more realistic for your situation.
Some trials require specific tissue types, certain markers, or additional analysis. Planning tissue preservation early may help you avoid being limited when a promising trial appears.
(Important: trial criteria vary. Not all trials require special tissue handling.)
Sometimes. But many trials are regional, and some have partner sites.
Often earlier than people think—especially if you want time to plan tissue needs and eligibility requirements.
Clinical Trials provide access to emerging therapies. Trial eligibility can depend on your diagnosis, prior treatment history, and sometimes tissue availability/requirements.
Clinical trials can offer access to new approaches earlier than standard availability. For many patients, a trial isn’t a last resort—it’s a strategic option.
Patients often feel buried by:
Trial matching support helps narrow the field to options that are more realistic for your situation.
Some trials require specific tissue types, certain markers, or additional analysis. Planning tissue preservation early may help you avoid being limited when a promising trial appears.
(Important: trial criteria vary. Not all trials require special tissue handling.)
Who is this for?
Clinical trial matching may be especially important for patients with advanced, recurrent, rare, or difficult-to-treat cancers. Genomic sequencing can help identify trial opportunities by matching tumor mutations or biomarkers to investigational therapies. NCI-MATCH demonstrated that people with advanced cancer may benefit from genomic sequencing to help guide treatment planning and trial matching.
Cancer types commonly associated with clinical trial searches include:
Lung Cancer
Lung cancer has a large clinical trial ecosystem, especially around early detection, targeted therapy, immunotherapy, and advanced-stage disease.
Breast Cancer
Breast cancer has strong advocacy, broad patient awareness, and many clinical trials focused on subtypes, recurrence risk, metastatic disease, and new therapies.
Colorectal Cancer
Colorectal cancer trials may involve targeted therapy, immunotherapy, biomarker-directed treatment, and recurrence prevention.
Prostate Cancer
Advanced prostate cancer patients may seek clinical trials involving targeted therapy, radiopharmaceuticals, immunotherapy, or genomic markers.
Melanoma
Melanoma remains a major area of immunotherapy and personalized therapy research.
Sometimes. But many trials are regional, and some have partner sites.
Often earlier than people think—especially if you want time to plan tissue needs and eligibility requirements.
